Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Velayudhan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Genome Editing|January 6, 2023
Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2Anila George, Nithin Sam Ravi, Kirti Prasad, et al.
Frontiers in Pharmacology|June 16, 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib <i>in vitro</i> and reduces disease burden <i>in vivo</i>Bharathi M Rajamani, Raveen Stephen Stallon Illangeswaran, Esther Sathya Bama Benjamin, et al.
Human Gene Therapy|September 6, 2021
Preferential Expansion of Human CD34<sup>+</sup>CD133<sup>+</sup>CD90<sup>+</sup> Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene TherapyAbisha Crystal Christopher, Vigneshwaran Venkatesan, Karthik V Karuppusamy, et al.
Journal of Medical Genetics|March 9, 2023
Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysisGaurav Joshi, Nancy Beryl Janet Arthur, Thenral S Geetha, et al.
Molecular Therapy. Nucleic Acids|May 31, 2024
Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editorsKirti Prasad, Nivedhitha Devaraju, Anila George, et al.
Frontiers in Molecular Biosciences|April 17, 2024
Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAsSmitha Ijee, Karthik Chambayil, Anurag Dutta Chaudhury, et al.
Elife|February 11, 2022
Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobinNithin Sam Ravi, Beeke Wienert, Stacia K Wyman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2024
Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expressionVignesh Rajendiran, Nivedhitha Devaraju, Mahdi Haddad, et al.
Molecular Therapy. Nucleic Acids|May 22, 2023
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathiesVigneshwaran Venkatesan, Abisha Crystal Christopher, Manuel Rhiel, et al.
Regenerative Medicine|September 13, 2018
Quality control guidelines for clinical-grade human induced pluripotent stem cell linesStephen Sullivan, Glyn N Stacey, Chihiro Akazawa, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Genome Editing|January 6, 2023
Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2Anila George, Nithin Sam Ravi, Kirti Prasad, et al.
Frontiers in Pharmacology|June 16, 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib <i>in vitro</i> and reduces disease burden <i>in vivo</i>Bharathi M Rajamani, Raveen Stephen Stallon Illangeswaran, Esther Sathya Bama Benjamin, et al.
Human Gene Therapy|September 6, 2021
Preferential Expansion of Human CD34<sup>+</sup>CD133<sup>+</sup>CD90<sup>+</sup> Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene TherapyAbisha Crystal Christopher, Vigneshwaran Venkatesan, Karthik V Karuppusamy, et al.
Journal of Medical Genetics|March 9, 2023
Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysisGaurav Joshi, Nancy Beryl Janet Arthur, Thenral S Geetha, et al.
Molecular Therapy. Nucleic Acids|May 31, 2024
Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editorsKirti Prasad, Nivedhitha Devaraju, Anila George, et al.
Frontiers in Molecular Biosciences|April 17, 2024
Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAsSmitha Ijee, Karthik Chambayil, Anurag Dutta Chaudhury, et al.
Elife|February 11, 2022
Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobinNithin Sam Ravi, Beeke Wienert, Stacia K Wyman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2024
Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expressionVignesh Rajendiran, Nivedhitha Devaraju, Mahdi Haddad, et al.
Molecular Therapy. Nucleic Acids|May 22, 2023
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathiesVigneshwaran Venkatesan, Abisha Crystal Christopher, Manuel Rhiel, et al.
Regenerative Medicine|September 13, 2018
Quality control guidelines for clinical-grade human induced pluripotent stem cell linesStephen Sullivan, Glyn N Stacey, Chihiro Akazawa, et al.
Pageof 4